-
2
-
-
70949107842
-
Inflammatory bowel disease
-
Abraham C., & Cho J.H. Inflammatory bowel disease. N. Engl. J. Med. 361, 2066-2078 (2009
-
(2009)
N. Engl. J. Med
, vol.361
, pp. 2066-2078
-
-
Abraham, C.1
Cho, J.H.2
-
3
-
-
84856083002
-
Crosstalk between B lymphocytes, microbiota and the intestinal epithelium governs immunity versus metabolism in the gut
-
Shulzhenko N., et al. Crosstalk between B lymphocytes, microbiota and the intestinal epithelium governs immunity versus metabolism in the gut. Nat. Med. 17, 1585-1593 (2011
-
(2011)
Nat. Med
, vol.17
, pp. 1585-1593
-
-
Shulzhenko, N.1
-
4
-
-
77958505148
-
Galt: Organization and dynamics leading to iga synthesis
-
Suzuki K., Kawamoto S., Maruya M., & Fagarasan S. GALT: organization and dynamics leading to IgA synthesis. Adv. Immunol. 107, 153-185 (2010
-
(2010)
Adv. Immunol
, vol.107
, pp. 153-185
-
-
Suzuki, K.1
Kawamoto, S.2
Maruya, M.3
Fagarasan, S.4
-
5
-
-
77958466150
-
Innate signaling networks in mucosal IgA class witching
-
Chorny A., Puga I., & Cerutti A. Innate signaling networks in mucosal IgA class witching. Adv. Immunol. 107, 31-69 (2010
-
(2010)
Adv. Immunol
, vol.107
, pp. 31-69
-
-
Chorny, A.1
Puga, I.2
Cerutti, A.3
-
6
-
-
50249179101
-
Vitamin effects on the immune system: Vitamins A andDtake centre stage
-
Mora J.R., Iwata M., & von Andrian U.H. Vitamin effects on the immune system: vitamins A andDtake centre stage. Nat. Rev. Immunol. 8, 685-698 (2008
-
(2008)
Nat. Rev. Immunol
, vol.8
, pp. 685-698
-
-
Mora, J.R.1
Iwata, M.2
Von Andrian, U.H.3
-
7
-
-
0024445451
-
Transforming growth factor beta induces IgA production and acts additively with interleukin 5 for IgA production
-
Sonoda E., et al. Transforming growth factor beta induces IgA production and acts additively with interleukin 5 for IgA production. J. Exp. Med. 170, 1415-1420 (1989
-
(1989)
J. Exp. Med
, vol.170
, pp. 1415-1420
-
-
Sonoda, E.1
-
8
-
-
0033697670
-
TGF-beta receptor controls B cell responsiveness and induction of IgA in vivo
-
Cazac B.B., & Roes J. TGF-beta receptor controls B cell responsiveness and induction of IgA in vivo. Immunity 13, 443-451 (2000
-
(2000)
Immunity
, vol.13
, pp. 443-451
-
-
Cazac, B.B.1
Roes, J.2
-
9
-
-
79954486763
-
Regulatory tcells and foxp3
-
Rudensky A.Y. Regulatory Tcells and Foxp3. Immunol. Rev. 241, 260-268 (2011
-
(2011)
Immunol. Rev
, vol.241
, pp. 260-268
-
-
Rudensky, A.Y.1
-
10
-
-
0027521572
-
Interleukin-10-deficient mice develop chronic enterocolitis
-
Kuhn R., Lohler J., Rennick D., Rajewsky K., & Muller W. Interleukin-10-deficient mice develop chronic enterocolitis. Cell 75, 263-274 (1993
-
(1993)
Cell
, vol.75
, pp. 263-274
-
-
Kuhn, R.1
Lohler, J.2
Rennick, D.3
Rajewsky, K.4
Muller, W.5
-
11
-
-
41549159660
-
Regulatory T cell-derived interleukin-10 limits inflammation at environmental interfaces
-
Rubtsov Y.P., et al. Regulatory T cell-derived interleukin-10 limits inflammation at environmental interfaces. Immunity 28, 546-558 (2008
-
(2008)
Immunity
, vol.28
, pp. 546-558
-
-
Rubtsov, Y.P.1
-
12
-
-
84900448316
-
Macrophage-restricted interleukin-10 receptor deficiency, but not IL-10 deficiency, causes severe spontaneous colitis
-
Zigmond E., et al. Macrophage-restricted interleukin-10 receptor deficiency, but not IL-10 deficiency, causes severe spontaneous colitis. Immunity 15, 720-733 (2014
-
(2014)
Immunity
, vol.15
, pp. 720-733
-
-
Zigmond, E.1
-
13
-
-
79954608612
-
Interleukin-10 signaling in regulatory T cells is required for suppression of Th17 cell-mediated inflammation
-
Chaudhry A., et al. Interleukin-10 signaling in regulatory T cells is required for suppression of Th17 cell-mediated inflammation. Immunity 34, 566-578 (2011
-
(2011)
Immunity
, vol.34
, pp. 566-578
-
-
Chaudhry, A.1
-
14
-
-
79954620910
-
+ t cells in an interleukin-10-dependent manner
-
+ T cells in an interleukin-10-dependent manner. Immunity 34, 554-565 (2011
-
(2011)
Immunity
, vol.34
, pp. 554-565
-
-
Huber, S.1
-
16
-
-
0347785480
-
Control of regulatory tcell development by the transcription factor foxp3
-
Hori S., Nomura T., & Sakaguchi S.Control of regulatory Tcell development by the transcription factor Foxp3. Science 299, 1057-1061 (2003
-
(2003)
Science
, vol.299
, pp. 1057-1061
-
-
Hori, S.1
Nomura, T.2
Sakaguchi, S.3
-
17
-
-
0348223787
-
+ regulatory T cells by TGF-beta induction of transcription factor Foxp3
-
+ regulatory T cells by TGF-beta induction of transcription factor Foxp3. J. Exp. Med. 198, 1875-1886 (2003
-
(2003)
J. Exp. Med
, vol.198
, pp. 1875-1886
-
-
Chen, W.1
-
19
-
-
65449136307
-
A central role for induced regulatory T cells in tolerance induction in experimental colitis
-
Haribhai D., et al. A central role for induced regulatory T cells in tolerance induction in experimental colitis. J. Immunol. 182, 3461-3468 (2009
-
(2009)
J. Immunol
, vol.182
, pp. 3461-3468
-
-
Haribhai, D.1
-
20
-
-
73349099737
-
A dominant, coordinated T regulatory cell-IgA response to the intestinal microbiota
-
Cong Y., Feng T., Fujihashi K., Schoeb T.R., & Elson C.O. A dominant, coordinated T regulatory cell-IgA response to the intestinal microbiota. Proc. Natl. Acad. Sci. USA 106, 19256-19261 (2009
-
(2009)
Proc. Natl. Acad. Sci. USA
, vol.106
, pp. 19256-19261
-
-
Cong, Y.1
Feng, T.2
Fujihashi, K.3
Schoeb, T.R.4
Elson, C.O.5
-
22
-
-
0027224059
-
Clinicopathologic study of dextran sulfate sodium experimental murine colitis
-
Cooper H.S., Murthy S.N., Shah R.S., & Sedergran D.J. Clinicopathologic study of dextran sulfate sodium experimental murine colitis. Lab. Invest. 69, 238-249 (1993
-
(1993)
Lab. Invest
, vol.69
, pp. 238-249
-
-
Cooper, H.S.1
Murthy, S.N.2
Shah, R.S.3
Sedergran, D.J.4
-
23
-
-
0025181580
-
A novel method in the induction of reliable experimental acute and chronic ulcerative colitis in mice
-
Okayasu I., et al. A novel method in the induction of reliable experimental acute and chronic ulcerative colitis in mice. Gastroenterology 98, 694-702 (1990
-
(1990)
Gastroenterology
, vol.98
, pp. 694-702
-
-
Okayasu, I.1
-
24
-
-
0028006855
-
Dextran sulfate sodium-induced colitis occurs in severe combined immunodeficient mice
-
Dieleman L.A., et al. Dextran sulfate sodium-induced colitis occurs in severe combined immunodeficient mice. Gastroenterology 107, 1643-1652 (1994
-
(1994)
Gastroenterology
, vol.107
, pp. 1643-1652
-
-
Dieleman, L.A.1
-
25
-
-
79954629814
-
The effects of foxp3-expressing regulatory tcells expanded with cd28 superagonist antibody in dss-induced mice colitis
-
Chen J., et al. The effects of Foxp3-expressing regulatory Tcells expanded with CD28 superagonist antibody in DSS-induced mice colitis. Int. Immunopharmacol. 11, 610-617 (2011
-
(2011)
Int. Immunopharmacol
, vol.11
, pp. 610-617
-
-
Chen, J.1
-
26
-
-
0030666959
-
Suppressive role of B cells in chronic colitis of Tcell receptor alpha mutant mice
-
Mizoguchi A., Mizoguchi E., Smith R.N., Preffer F.I., & Bhan A.K. Suppressive role of B cells in chronic colitis of Tcell receptor alpha mutant mice. J. Exp. Med. 186, 1749-1756 (1997
-
(1997)
J. Exp. Med
, vol.186
, pp. 1749-1756
-
-
Mizoguchi, A.1
Mizoguchi, E.2
Smith, R.N.3
Preffer, F.I.4
Bhan, A.K.5
-
27
-
-
84855642249
-
B cells exposed to enterobacterial components suppress development of experimental colitis
-
Schmidt E.G., et al. B cells exposed to enterobacterial components suppress development of experimental colitis. Inflamm. Bowel Dis. 18, 284-293 (2012
-
(2012)
Inflamm. Bowel Dis
, vol.18
, pp. 284-293
-
-
Schmidt, E.G.1
-
28
-
-
0037441998
-
B cell developmental requirement for the galpha i2 gene
-
Dalwadi H., et al. B cell developmental requirement for the Galpha i2 gene. J. Immunol. 170, 1707-1715 (2003
-
(2003)
J. Immunol
, vol.170
, pp. 1707-1715
-
-
Dalwadi, H.1
-
29
-
-
79951825006
-
IL-10-producing regulatory B10 cells inhibit intestinal injury in a mouse model
-
Yanaba K., et al. IL-10-producing regulatory B10 cells inhibit intestinal injury in a mouse model. Am. J. Pathol. 178, 735-743 (2011
-
(2011)
Am. J. Pathol
, vol.178
, pp. 735-743
-
-
Yanaba, K.1
-
30
-
-
84899106298
-
IL-10-producing regulatory B cells induced by IL-33 (Breg(IL-33)) effectively attenuate mucosal inflammatory responses in the gut
-
Sattler S., et al. IL-10-producing regulatory B cells induced by IL-33 (Breg(IL-33)) effectively attenuate mucosal inflammatory responses in the gut. J. Autoimmun. 50, 107-122 (2014
-
(2014)
J. Autoimmun
, vol.50
, pp. 107-122
-
-
Sattler, S.1
-
31
-
-
84859376769
-
A novel il-10-independent regulatory role for b cells in suppressing autoimmunity by maintenance of regulatory tcells via gitr ligand
-
Ray A., Basu S., Williams C.B., Salzman N.H., & Dittel B.N. A novel IL-10-independent regulatory role for B cells in suppressing autoimmunity by maintenance of regulatory Tcells via GITR ligand. J. Immunol. 188, 3188-3198 (2012
-
(2012)
J. Immunol
, vol.188
, pp. 3188-3198
-
-
Ray, A.1
Basu, S.2
Williams, C.B.3
Salzman, N.H.4
Dittel, B.N.5
-
32
-
-
70149098555
-
Nonredundant roles for B cell-derived IL-10 in immune counter-regulation
-
Madan R., et al. Nonredundant roles for B cell-derived IL-10 in immune counter-regulation. J. Immunol. 183, 2312-2320 (2009
-
(2009)
J. Immunol
, vol.183
, pp. 2312-2320
-
-
Madan, R.1
-
33
-
-
84863480832
-
Pathogenic and regulatory roles for B cells in experimental autoimmune encephalomyelitis
-
Mann M.K., Ray A., Basu S., Karp C.L., & Dittel B.N. Pathogenic and regulatory roles for B cells in experimental autoimmune encephalomyelitis. Autoimmunity 45, 388-399 (2012
-
(2012)
Autoimmunity
, vol.45
, pp. 388-399
-
-
Mann, M.K.1
Ray, A.2
Basu, S.3
Karp, C.L.4
Dittel, B.N.5
-
34
-
-
0034705397
-
A primitive T cell-independent mechanism of intestinal mucosal IgA responses to commensal bacteria
-
Macpherson A.J., et al. A primitive T cell-independent mechanism of intestinal mucosal IgA responses to commensal bacteria. Science 288, 2222-2226 (2000
-
(2000)
Science
, vol.288
, pp. 2222-2226
-
-
MacPherson, A.J.1
-
35
-
-
34047123052
-
Prevention of experimental colitis by parenteral administration of a pathogen-derived immunomodulatory molecule
-
Braat H., et al. Prevention of experimental colitis by parenteral administration of a pathogen-derived immunomodulatory molecule. Gut 56, 351-357 (2007
-
(2007)
Gut
, vol.56
, pp. 351-357
-
-
Braat, H.1
-
37
-
-
0036197923
-
Chronic intestinal inflammatory condition generates IL-10-producing regulatory B cell subset characterized by CD1d upregulation
-
Mizoguchi A., Mizoguchi E., Takedatsu H., Blumberg R.S., & Bhan A.K. Chronic intestinal inflammatory condition generates IL-10-producing regulatory B cell subset characterized by CD1d upregulation. Immunity 16, 219-230 (2002
-
(2002)
Immunity
, vol.16
, pp. 219-230
-
-
Mizoguchi, A.1
Mizoguchi, E.2
Takedatsu, H.3
Blumberg, R.S.4
Bhan, A.K.5
-
38
-
-
33947283177
-
+ tregulatory cells and il-10 via b7 is essential for recovery from experimental autoimmune encephalomyelitis
-
+ Tregulatory cells and IL-10 via B7 is essential for recovery from experimental autoimmune encephalomyelitis. J. Immunol. 178, 3447-3456 (2007
-
(2007)
J. Immunol
, vol.178
, pp. 3447-3456
-
-
Mann, M.K.1
Maresz, K.2
Shriver, L.P.3
Tan, Y.4
Dittel, B.N.5
-
39
-
-
84857444508
-
B cell-intrinsic myd88 signaling prevents the lethal dissemination of commensal bacteria during colonic damage
-
Kirkland D., et al. B cell-intrinsic MyD88 signaling prevents the lethal dissemination of commensal bacteria during colonic damage. Immunity 36, 228-238 (2012
-
(2012)
Immunity
, vol.36
, pp. 228-238
-
-
Kirkland, D.1
-
40
-
-
28444443002
-
Reversal of experimental colitis disease activity in mice following administration of an adenoviral IL-10 vector
-
Sasaki M., et al. Reversal of experimental colitis disease activity in mice following administration of an adenoviral IL-10 vector. J. Inflamm. 2, 13 (2005
-
(2005)
J. Inflamm
, vol.2
, pp. 13
-
-
Sasaki, M.1
-
41
-
-
0031900372
-
Role of interleukin-10 in a murine model of dextran sulfate sodium-induced colitis
-
Tomoyose M., Mitsuyama K., Ishida H., Toyonaga A., & Tanikawa K. Role of interleukin-10 in a murine model of dextran sulfate sodium-induced colitis. Scand. J. Gastroenterol. 33, 435-440 (1998
-
(1998)
Scand. J. Gastroenterol
, vol.33
, pp. 435-440
-
-
Tomoyose, M.1
Mitsuyama, K.2
Ishida, H.3
Toyonaga, A.4
Tanikawa, K.5
-
42
-
-
79953833268
-
Treatment ofmice with dextran sulfate sodium-induced colitis with human interleukin 10 secreted by transformed Bifidobacterium longum
-
Yao J., et al. Treatment ofmice with dextran sulfate sodium-induced colitis with human interleukin 10 secreted by transformed Bifidobacterium longum. Mol. Pharm. 8, 488-497 (2011
-
(2011)
Mol. Pharm
, vol.8
, pp. 488-497
-
-
Yao, J.1
-
43
-
-
0029094609
-
Abnormal B lymphocyte development, activation, and differentiation in mice that lack or overexpress the CD19 signal transduction molecule
-
Engel P., et al. Abnormal B lymphocyte development, activation, and differentiation in mice that lack or overexpress the CD19 signal transduction molecule. Immunity 3, 39-50 (1995
-
(1995)
Immunity
, vol.3
, pp. 39-50
-
-
Engel, P.1
-
44
-
-
79151485447
-
Induction and activation of adaptive immune populations during acute and chronic phases of a murine model of experimental colitis
-
Hall L.J., et al. Induction and activation of adaptive immune populations during acute and chronic phases of a murine model of experimental colitis. Dig. Dis. Sci. 56, 79-89 (2011
-
(2011)
Dig. Dis. Sci
, vol.56
, pp. 79-89
-
-
Hall, L.J.1
-
45
-
-
79251528850
-
Microbiota: Dual-faceted player in experimental colitis
-
Feng T., Elson C.O., & Cong Y. Microbiota: dual-faceted player in experimental colitis. Gut Microbes 1, 388-391 (2010
-
(2010)
Gut Microbes
, vol.1
, pp. 388-391
-
-
Feng, T.1
Elson, C.O.2
Cong, Y.3
-
46
-
-
0030456897
-
Experimental autoimmune encephalomyelitis induction in genetically B cell-deficient mice
-
Wolf S.D., Dittel B.N., Hardardottir F., & Janeway C.A. Jr. Experimental autoimmune encephalomyelitis induction in genetically B cell-deficient mice. J. Exp. Med. 184, 2271-2278 (1996
-
(1996)
J. Exp. Med
, vol.184
, pp. 2271-2278
-
-
Wolf, S.D.1
Dittel, B.N.2
Hardardottir, F.3
Janeway, C.A.4
-
47
-
-
0036795531
-
B cells regulate autoimmunity by provision of IL-10
-
Fillatreau S., Sweenie C.H., McGeachy M.J., Gray D., & Anderton S.M. B cells regulate autoimmunity by provision of IL-10. Nat. Immunol. 3, 944-950 (2002
-
(2002)
Nat. Immunol
, vol.3
, pp. 944-950
-
-
Fillatreau, S.1
Sweenie, C.H.2
McGeachy, M.J.3
Gray, D.4
Anderton, S.M.5
-
48
-
-
77956895769
-
Regulatory b cells (b10 cells) and regulatory t cells have independent roles in controlling experimental autoimmune encephalomyelitis initiation and late-phase immunopathogenesis
-
Matsushita T., Horikawa M., Iwata Y., & Tedder T.F. Regulatory B cells (B10 cells) and regulatory T cells have independent roles in controlling experimental autoimmune encephalomyelitis initiation and late-phase immunopathogenesis. J. Immunol. 185, 2240-2252 (2010
-
(2010)
J. Immunol
, vol.185
, pp. 2240-2252
-
-
Matsushita, T.1
Horikawa, M.2
Iwata, Y.3
Tedder, T.F.4
-
49
-
-
84871173673
-
IL-10 produced by induced regulatory T cells (iTregs) controls colitis and pathogenic ex-iTregs during immunotherapy
-
Schmitt E.G., et al. IL-10 produced by induced regulatory T cells (iTregs) controls colitis and pathogenic ex-iTregs during immunotherapy. J. Immunol. 189, 5638-5648 (2012
-
(2012)
J. Immunol
, vol.189
, pp. 5638-5648
-
-
Schmitt, E.G.1
-
50
-
-
77249137663
-
+ regulatory tcells th17 effector cells, and cytokine environment in inflammatory bowel disease
-
+ regulatory Tcells, Th17 effector cells, and cytokine environment in inflammatory bowel disease. J. Clin. Immunol. 30, 80-89 (2010
-
(2010)
J. Clin. Immunol
, vol.30
, pp. 80-89
-
-
Eastaff-Leung, N.1
Mabarrack, N.2
Barbour, A.3
Cummins, A.4
Barry, S.5
-
51
-
-
77951060733
-
Ox40 is required for regulatory tcell-mediated control ofcolitis
-
Griseri T., Asquith M., Thompson C., & Powrie F. OX40 is required for regulatory Tcell-mediated control ofcolitis. J. Exp.Med.207, 699-709(2010
-
(2010)
J. Exp.Med
, vol.207
, pp. 699-709
-
-
Griseri, T.1
Asquith, M.2
Thompson, C.3
Powrie, F.4
-
52
-
-
33750375612
-
+ t cells during cure of colitis
-
+ T cells during cure of colitis. J. Immunol. 177, 5852-5860 (2006
-
(2006)
J. Immunol
, vol.177
, pp. 5852-5860
-
-
Uhlig, H.H.1
-
53
-
-
84879475809
-
On the road to tolerance-generation and migration of gut regulatory Tcells
-
Pabst O., & Bernhardt G. On the road to tolerance-generation and migration of gut regulatory Tcells. Eur. J. Immunol. 43, 1422-1425 (2013
-
(2013)
Eur. J. Immunol
, vol.43
, pp. 1422-1425
-
-
Pabst, O.1
Bernhardt, G.2
-
54
-
-
34548742977
-
Reciprocal generation of Th1/Th17 and T(reg) cells by B1 and B2 B cells
-
Zhong X., et al. Reciprocal generation of Th1/Th17 and T(reg) cells by B1 and B2 B cells. Eur. J. Immunol. 37, 2400-2404 (2007
-
(2007)
Eur. J. Immunol
, vol.37
, pp. 2400-2404
-
-
Zhong, X.1
-
55
-
-
55249124839
-
+ Treg population via TGF-beta3
-
+ Treg population via TGF-beta3. Eur. J. Immunol. 38, 2488-2498 (2008
-
(2008)
Eur. J. Immunol
, vol.38
, pp. 2488-2498
-
-
Shah, S.1
Qiao, L.2
-
56
-
-
79956224216
-
Mice lacking endogenous il-10-producing regulatory b cells develop exacerbated disease and present with an increased frequency of th1/th17 but a decrease in regulatory t cells
-
Carter N.A., et al. Mice lacking endogenous IL-10-producing regulatory B cells develop exacerbated disease and present with an increased frequency of Th1/Th17 but a decrease in regulatory T cells. J. Immunol. 186, 5569-5579 (2011
-
(2011)
J. Immunol
, vol.186
, pp. 5569-5579
-
-
Carter, N.A.1
-
57
-
-
85062929402
-
+cd24hicd38hi b cells maintain regulatory t cells while limiting th1 and th17 differentiation
-
173ra123
-
+CD24hiCD38hi B cells maintain regulatory T cells while limiting TH1 and TH17 differentiation. Sci. Transl. Med. 5, 173ra123 (2013
-
(2013)
Sci. Transl. Med
, vol.5
-
-
Flores-Borja, F.1
-
58
-
-
84860520258
-
Regulatory T cells induced by mucosal B cells alleviate allergic airway hypersensitivity
-
Chu K.H., & Chiang B.L. Regulatory T cells induced by mucosal B cells alleviate allergic airway hypersensitivity. Am. J. Respir. Cell Mol. Biol. 46, 651-659 (2012
-
(2012)
Am. J. Respir. Cell Mol. Biol
, vol.46
, pp. 651-659
-
-
Chu, K.H.1
Chiang, B.L.2
-
59
-
-
0036838536
-
+ regulatory t cells suppress antigen-specific autoreactive immune responses and central nervous system inflammation during active experimental autoimmune encephalomyelitis
-
+ regulatory T cells suppress antigen-specific autoreactive immune responses and central nervous system inflammation during active experimental autoimmune encephalomyelitis. J. Immunol. 169, 4712-4716 (2002
-
(2002)
J. Immunol
, vol.169
, pp. 4712-4716
-
-
Kohm, A.P.1
Carpentier, P.A.2
Anger, H.A.3
Miller, S.D.4
-
60
-
-
77953633327
-
TGF-{beta}-induced myelin peptide-specific regulatory Tcells mediate antigen-specific suppression of induction of experimental autoimmune encephalomyelitis
-
Zhang H., Podojil J.R., Chang J., Luo X., & Miller S.D. TGF-{beta}-induced myelin peptide-specific regulatory Tcells mediate antigen-specific suppression of induction of experimental autoimmune encephalomyelitis. J. Immunol. 184, 6629-6636 (2010
-
(2010)
J. Immunol
, vol.184
, pp. 6629-6636
-
-
Zhang, H.1
Podojil, J.R.2
Chang, J.3
Luo, X.4
Miller, S.D.5
-
61
-
-
1042269477
-
+ regulatory t cells
-
+ regulatory T cells. Int. Immunol. 16, 249-256 (2004
-
(2004)
Int. Immunol
, vol.16
, pp. 249-256
-
-
Zhang, X.1
-
62
-
-
84888246103
-
Therapeutic evaluation of ex vivo-generated versus natural regulatory T-cells in a mouse model of chronic gut inflammation
-
Karlsson F., et al. Therapeutic evaluation of ex vivo-generated versus natural regulatory T-cells in a mouse model of chronic gut inflammation. Inflamm. Bowel. Dis. 19, 2282-2294 (2013
-
(2013)
Inflamm. Bowel. Dis
, vol.19
, pp. 2282-2294
-
-
Karlsson, F.1
-
63
-
-
84899539920
-
+ B cell depletion in systemic autoimmune diseases: Common mechanism of inhibition or diseasespecific effect on humoral immunity?
-
+ B cell depletion in systemic autoimmune diseases: common mechanism of inhibition or diseasespecific effect on humoral immunity?. Biomed Res. Int. 2014, 973609 (2014
-
(2014)
Biomed Res. Int
, vol.2014
, pp. 973609
-
-
Pateinakis, P.1
Pyrpasopoulou, A.2
-
64
-
-
39049142995
-
B-cell depletion with rituximab in relapsing-remitting multiple sclerosis
-
Hauser S.L., et al. B-cell depletion with rituximab in relapsing-remitting multiple sclerosis. N. Engl. J. Med. 358, 676-688 (2008
-
(2008)
N. Engl. J. Med
, vol.358
, pp. 676-688
-
-
Hauser, S.L.1
-
65
-
-
41849116363
-
Rituximab in relapsing-remitting multiple sclerosis: A 72-week, open-label, phase i trial
-
Bar-Or A., et al. Rituximab in relapsing-remitting multiple sclerosis: a 72-week, open-label, phase I trial. Ann. Neurol. 63, 395-400 (2008
-
(2008)
Ann. Neurol
, vol.63
, pp. 395-400
-
-
Bar-Or, A.1
-
66
-
-
80053566144
-
Randomised placebo-controlled trial of rituximab (anti-CD20) in active ulcerative colitis
-
Leiper K., et al. Randomised placebo-controlled trial of rituximab (anti-CD20) in active ulcerative colitis. Gut 60, 1520-1526 (2011
-
(2011)
Gut
, vol.60
, pp. 1520-1526
-
-
Leiper, K.1
-
67
-
-
84896464636
-
New biologic therapeutics for ulcerative colitis and Crohn's disease
-
Mozaffari S., Nikfar S., Abdolghaffari A.H., & Abdollahi M. New biologic therapeutics for ulcerative colitis and Crohn's disease. Exp. Opin. Biol. Ther. 14, 583-600 (2014
-
(2014)
Exp. Opin. Biol. Ther
, vol.14
, pp. 583-600
-
-
Mozaffari, S.1
Nikfar, S.2
Abdolghaffari, A.H.3
Abdollahi, M.4
-
68
-
-
36749004359
-
Exacerbation of ulcerative colitis after rituximab salvage therapy
-
Goetz M., Atreya R., Ghalibafian M., Galle P.R., & Neurath M.F. Exacerbation of ulcerative colitis after rituximab salvage therapy. Inflamm. Bowel Dis. 13, 1365-1368 (2007
-
(2007)
Inflamm. Bowel Dis
, vol.13
, pp. 1365-1368
-
-
Goetz, M.1
Atreya, R.2
Ghalibafian, M.3
Galle, P.R.4
Neurath, M.F.5
-
69
-
-
42549142171
-
Ulcerative colitis following B lymphocyte depletion with rituximab in a patient with Graves disease
-
El Fassi D., Nielsen C.H., Kjeldsen J., Clemmensen O., & Hegedus L. Ulcerative colitis following B lymphocyte depletion with rituximab in a patient with Graves disease. Gut 57, 714-715 (2008
-
(2008)
Gut
, vol.57
, pp. 714-715
-
-
El Fassi, D.1
Nielsen, C.H.2
Kjeldsen, J.3
Clemmensen, O.4
Hegedus, L.5
-
70
-
-
77954362764
-
Severe ulcerative colitis after rituximab therapy
-
Ardelean D.S., et al. Severe ulcerative colitis after rituximab therapy. Pediatrics 126, e243-e246 (2010
-
(2010)
Pediatrics
, vol.126
, pp. e243-e246
-
-
Ardelean, D.S.1
-
71
-
-
80052905956
-
Ulcerative colitis: Exceptional consequence after rituximab therapy
-
Sekkach Y., et al. [Ulcerative colitis: exceptional consequence after rituximab therapy]. Ann. Pharm. Fr. 69, 265-269 (2011
-
(2011)
Ann. Pharm. Fr
, vol.69
, pp. 265-269
-
-
Sekkach, Y.1
-
72
-
-
0037310884
-
Anti-cd2o chimeric monoclonal antibody (rituximab) treatment of immune-mediated thrombocytopenia associated with crohn's disease
-
Papadakis K.A., Rosenbloom B., & Targan S.R. Anti-CD2O chimeric monoclonal antibody (rituximab) treatment of immune-mediated thrombocytopenia associated with Crohn's disease. Gastroenterology 124, 583 (2003
-
(2003)
Gastroenterology
, vol.124
, pp. 583
-
-
Papadakis, K.A.1
Rosenbloom, B.2
Targan, S.R.3
-
73
-
-
79955563176
-
Cytomegalovirus colitis and hypo-IgG after rituximab therapy for rheumatoid arthritis
-
Vallet H., Houitte R., Azria A., & Mariette X. Cytomegalovirus colitis and hypo-IgG after rituximab therapy for rheumatoid arthritis. J. Rheumatol. 38, 965-966 (2011
-
(2011)
J. Rheumatol
, vol.38
, pp. 965-966
-
-
Vallet, H.1
Houitte, R.2
Azria, A.3
Mariette, X.4
-
74
-
-
79952447203
-
Colitis associated with active systemic lupus erythematosus successfully treated with rituximab
-
Tayal V., Chiu Y.H., George E., & Mane S. Colitis associated with active systemic lupus erythematosus successfully treated with rituximab. J. Clin. Rheumatol. 17, 79-82 (2011
-
(2011)
J. Clin. Rheumatol
, vol.17
, pp. 79-82
-
-
Tayal, V.1
Chiu, Y.H.2
George, E.3
Mane, S.4
-
75
-
-
0027275654
-
Treatment of dextran sulfate sodium-induced murine colitis by intracolonic cyclosporin
-
Murthy S.N., et al. Treatment of dextran sulfate sodium-induced murine colitis by intracolonic cyclosporin. Dig. Dis. Sci. 38, 1722-1734 (1993
-
(1993)
Dig. Dis. Sci
, vol.38
, pp. 1722-1734
-
-
Murthy, S.N.1
-
76
-
-
34347262689
-
Chemically induced mouse models of intestinal inflammation
-
Wirtz S., Neufert C., Weigmann B., & Neurath M.F. Chemically induced mouse models of intestinal inflammation. Nat. Protoc. 2, 541-546 (2007
-
(2007)
Nat. Protoc
, vol.2
, pp. 541-546
-
-
Wirtz, S.1
Neufert, C.2
Weigmann, B.3
Neurath, M.F.4
-
77
-
-
45949095703
-
Isolation of mouse small intestinal intraepithelial lymphocytes peyer's patch, and lamina propria cells
-
Chapter 3, Unit 3.19
-
Lefrancois L., & Lycke N. Isolation of mouse small intestinal intraepithelial lymphocytes, Peyer's patch, and lamina propria cells. Curr. Protoc. Immunol. Chapter 3, Unit 3.19 (2001
-
(2001)
Curr. Protoc. Immunol
-
-
Lefrancois, L.1
Lycke, N.2
-
78
-
-
84876008718
-
Anti-cd20 antibody promotes cancer escape via enrichment of tumor-evoked regulatory b cells expressing low levels of cd20 and cd137l
-
Bodogai M., et al. Anti-CD20 antibody promotes cancer escape via enrichment of tumor-evoked regulatory B cells expressing low levels of CD20 and CD137L. Cancer Res. 73, 2127-2138 (2013
-
(2013)
Cancer Res
, vol.73
, pp. 2127-2138
-
-
Bodogai, M.1
-
79
-
-
84873666112
-
Transient b-cell depletion with anti-cd20 in combination with proinsulin dna vaccine or oral insulin: Immunologic effects and efficacy in nod mice
-
Sarikonda G., et al. Transient B-cell depletion with anti-CD20 in combination with proinsulin DNA vaccine or oral insulin: immunologic effects and efficacy in NOD mice. PLoS One 8, e54712 (2013
-
(2013)
Plos One
, vol.8
, pp. e54712
-
-
Sarikonda, G.1
-
80
-
-
8444250163
-
Helminth infection protects mice from anaphylaxis via IL-10-producing B cells
-
Mangan N.E., et al. Helminth infection protects mice from anaphylaxis via IL-10-producing B cells. J. Immunol. 173, 6346-6356 (2004
-
(2004)
J. Immunol
, vol.173
, pp. 6346-6356
-
-
Mangan, N.E.1
|